These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19734741)

  • 21. History of the development of sulphasalazine in rheumatology.
    McConkey B
    Drugs; 1986; 32 Suppl 1():12-7. PubMed ID: 2877849
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymphoma-like presentation in suspected rheumatoid arthritis due to sulphasalazine hypersensitivity syndrome.
    Shenoy P; Misra R; Jain M; Agarwal V
    N Z Med J; 2008 Jun; 121(1276):102-5. PubMed ID: 18574514
    [No Abstract]   [Full Text] [Related]  

  • 23. Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature.
    Salouage I; El Aïdli S; Cherif F; Kastalli S; Zaiem A; Daghfous R
    Therapie; 2013; 68(6):423-6. PubMed ID: 24356191
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experience with sulphasalazine (salazopyrin) in the treatment of rheumatoid arthritis].
    Winkler V
    Orv Hetil; 1986 Aug; 127(34):2073-4, 2079-80. PubMed ID: 2876405
    [No Abstract]   [Full Text] [Related]  

  • 25. [A new cause of intra and extrahepatic cholangitis: the drug hypersensitivity syndrome or DRESS (Drug Rash with Eosinophilia and Systemic Symptoms)].
    Condat B; Zanditenas D; Collot V; Legoupil N; Cazals-Hatem D; Hauuy MP; Bonnet J; Ngo Y; Roucoules J; Blazquez M
    Gastroenterol Clin Biol; 2006 Jan; 30(1):142-6. PubMed ID: 16514397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucopenia, thrombocytopenia and lymphadenopathy associated with sulphasalazine.
    McKenna KE; Burrows D
    Clin Exp Dermatol; 1994 Sep; 19(5):419-20. PubMed ID: 7955504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sulfasalazine induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Siam AR; Hammoudeh M
    J Rheumatol; 1993 Jan; 20(1):207. PubMed ID: 8095074
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclosporin and sulfasalazine combination in the treatment of early rheumatoid arthritis.
    Rojkovich B; Hodinka L; Bálint G; Szegedi G; Varjú T; Tamási L; Molnár E; Szilágyi M; Szocsik K
    Scand J Rheumatol; 1999; 28(4):216-21. PubMed ID: 10503557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rheumatoid arthritis and anemia; various aspects concerning prevalence, pathogenesis, diagnosis and therapy].
    Houtman PM; Stenger AA; Bruyn GA
    Ned Tijdschr Geneeskd; 1992 Jun; 136(25):1217-8. PubMed ID: 1352041
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of non-steroidal anti-inflammatory drug induced enteropathy.
    Bjarnason I; Hopkinson N; Zanelli G; Prouse P; Smethurst P; Gumpel JM; Levi AJ
    Gut; 1990 Jul; 31(7):777-80. PubMed ID: 1973396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal sulfasalazine-induced eosinophilic myocarditis in a patient with periodic fever syndrome.
    Jeremic I; Vujasinovic-Stupar N; Terzic T; Damjanov N; Nikolic M; Bonaci-Nikolic B
    Med Princ Pract; 2015; 24(2):195-7. PubMed ID: 25531204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Side effect profile of 200 patients with inflammatory arthritides treated with sulphasalazine.
    Farr M; Scott DG; Bacon PA
    Drugs; 1986; 32 Suppl 1():49-53. PubMed ID: 2877853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic intracranial hypertension associated with sulphasalazine treatment.
    Nawashiro H
    Headache; 2008 Oct; 48(9):1383-4. PubMed ID: 18647179
    [No Abstract]   [Full Text] [Related]  

  • 34. Reversible encephalopathy due to sulfasalazine.
    Mut SE; Kutlu G; Ucler S; Erdal A; Inan LE
    Clin Neuropharmacol; 2008; 31(6):368-71. PubMed ID: 19050416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-cardiogenic pulmonary oedema induced by salazosulfapyridine.
    Saito T; Mori Y; Yoshida M; Maeta T; Koui F; Harada M
    Respirology; 2005 Sep; 10(4):545-7. PubMed ID: 16135183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axonal neuropathy with prolonged sulphasalazine use.
    Liedorp M; Voskuyl AE; Van Oosten BW
    Clin Exp Rheumatol; 2008; 26(4):671-2. PubMed ID: 18799104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal agranulocytosis with sulfasalazine therapy in rheumatoid arthritis.
    Canvin JM; el-Gabalawy HS; Chalmers IM
    J Rheumatol; 1993 May; 20(5):909-10. PubMed ID: 8101571
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemophagocytic syndrome occurring in polyarticular juvenile arthritis treated by salazopyrine].
    Bouayed K; Brik H; Zakari A; Mikou N; Dehbi F
    Arch Pediatr; 2006 Aug; 13(8):1156-7. PubMed ID: 16793243
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum sickness with pseudolymphomatous lymph node hyperplasia caused by salicylazosulfapyridine].
    Delage C; Lagacé R
    Union Med Can; 1975 Apr; 104(4):579-84. PubMed ID: 4911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.